| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67e277f7d6b1f47c78ac2dca_Butterfly_copy.avif |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67e277f79cfce1acda113640_Flower_shutterstock_156960281_(1)_copy.avif |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67e277f7d6b1f47c78ac2dca_Butterfly_copy.avif |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67e277fe4d9a279c22c50387_Think_Rare.avif |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67cea69dd0478b377e457b25_pediatric-.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67e2ce2b131a73c026c4f52b_graduation-cap.png |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67cac08cffa262069964e361_mic.svg |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67cac08d0143f467e244ac45_user.svg |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67cac08cd5d436b94c3cce80_link.svg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/682320da82feae5becc84e9a_Banner%20Sanofi%20RSV%20Report%20960x540px.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/682329bbff57c6e6453ed61a_Banner%201920x1080px%20Pfizer.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6806016d17eeb9dfe1523f9c_News%20-%20World%20Immunization%20Week%202025.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/685410be1e10f4801a9c914c_Advances%20in%20gene%20therapy%20for%20MLD%20and%20MPS%20I%20(1).webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541cd978db27db59b5e763_Smell%20and%20taste%20disorders%20in%20children%20with%20MPS.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541cba496492446afa6858_Short%20stature%20as%20a%20symptom%20of%20attenuated%20MPS%20I.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541cf150a11c37d83c7687_The%20new%20frame%20for%20Mucopolysaccharidoses.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541bcc597535c0f21f6de0_Genotype-phenotype%20insights%20in%20MPS%20I%20from%20the%20International%20Registry.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541c9eeb14d9bd2940e176_Open%20issues%20in%20Mucopolysaccharidosis%20type%20I-Hurler.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6966668afae999934e664d4a_MLD%20Tutorial.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/685410a8f6d016858e8fbd9e_Gene%20therapy%20progress%20for%20metachromatic%20leukodystrophy%20(1).webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/685410be1e10f4801a9c914c_Advances%20in%20gene%20therapy%20for%20MLD%20and%20MPS%20I%20(1).webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/685410df88432e1431098161_Leukodystrophies-%20a%20proposed%20classification%20system%20(1).webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/685410f59c7af4efc306ef2f_Peripheral%20neuropathy%20in%20metachromatic%20leukodystrophy.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6854110f20d44b4aaf8b7da0_Metachromatic%20leukodystrophy%20and%20transplantation%20(1).webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/682755786e9556ae7f3c27e4_brain-mri-hallmarks-alpha-mannosidosis%20(1).webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6852bd07c800c87aebc4c4c8_Recognizing%20alpha-mannosidosis%20in%20paediatric%20and%20adult%20patients.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6852bc3ba887df7ed1019896__Alpha-Mannosidosis-%20A%20rarely%20diagnosed%20MPS-like%20disease.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6852be325940ff4176ba7656_Velmanase%20alfa%20treatment.Efficacy%20and%20safety%20in%20alpha-mannosidosis.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6852bdb06ff1a88162b2287a_Long-term%20efficacy%20of%20velmanase%20alfa%20in%20alpha-mannosidosis.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/6852be6428656f2264f98026__Genotype%2C%20antibodies%20and%20velmanase%20alfa%20long-term%20outcomes.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/685410be1e10f4801a9c914c_Advances%20in%20gene%20therapy%20for%20MLD%20and%20MPS%20I%20(1).webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541cd978db27db59b5e763_Smell%20and%20taste%20disorders%20in%20children%20with%20MPS.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541cba496492446afa6858_Short%20stature%20as%20a%20symptom%20of%20attenuated%20MPS%20I.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541cf150a11c37d83c7687_The%20new%20frame%20for%20Mucopolysaccharidoses.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541bcc597535c0f21f6de0_Genotype-phenotype%20insights%20in%20MPS%20I%20from%20the%20International%20Registry.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68541c9eeb14d9bd2940e176_Open%20issues%20in%20Mucopolysaccharidosis%20type%20I-Hurler.webp |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e40f2f49bb6951f98d_67d329e100159fdc81a0b0c7_VAN%2520GYSEL%252C%2520DIRK.jpeg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e4868544284ac523af_67d329a0a5426471be9cfa44_UHLIG%252C%2520TORSTEN.jpeg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e4907e30f0a0ce9a91_67d328e84d1676a0031b99b9_Syrogiannopoulos%252C%2520George.jpeg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e456d5157f36ec4472_67d328a25fb0bd5793a10e3b_STEPHENSON%252C%2520Sir%2520TERENCE.jpeg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e3ea77044cbfcb8a32_67d327b7bb99ada25b5bbfeb_ROLAND%252C%2520DAMIAN.jpeg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e2057f1804047c382b_684fd1a07ec237ba29b395e0_MICHIE%252C%2520COLIN.jpeg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e10349c9a3859085cf_67d322a4635a2364e7c24a35_KUNZ%252C%2520BARBARA.jpeg |
| https://cdn.prod.website-files.com/67ceac80f908ae5359631d3a/68b302e0d941df603944675b_6800a54d8961cd0dc38b3b08_HENTSCHEL%252C%2520ROLAND.jpeg |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67c9c3ebaa6b1b43f23c75de_2025%20Logo%20EiP%20Institute.png |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/6814aa051c7e96a03e815126_linkedin.svg |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/69627eb5efb3f2fad1f989e4_X%20Logo%20Negative.png |
| https://cdn.prod.website-files.com/67c9c2ad6a599e678c541c64/67dc0fb0fd9268c9e371e4a7_x.svg |
Social
Social Data
Cost and overhead previously rendered this semi-public form of communication unfeasible.
But advances in social networking technology from 2004-2010 has made broader concepts of sharing possible.